Dr. Jason Ross is a physician-scientist in the Department of Radiation Oncology at Stanford University. He received his BS in Biological Sciences from Stanford University, where he conducted research in normal and cancer stem cell biology. He obtained his MD from Weill Cornell Medical College and his PhD from The Rockefeller University, where he studied breast cancer metastasis, as a member of the Tri-Institutional MD-PhD Program in New York City. He conducted postdoctoral research as a Kaplan Research Fellow with co-advisors Dr. Irving Weissman and Dr.

Dr. Sherri Rose is a Professor of Health Policy and Director of the Health Policy Data Science Lab at Stanford University. Her research is centered on developing and integrating innovative statistical machine learning approaches to improve human health and health equity. Within health policy, Dr. Rose works on ethical algorithms in health care, risk adjustment, chronic kidney disease, and health program evaluation.

Dr. Trung Hoang Minh Pham is an Assistant Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology at Stanford University. The Pham lab brings together immunology, tissue biology, microbiology, and genetics to study innate immunity and infection-induced tissue physiological adaptations. Their goal is to uncover mechanisms underlying tissue immunity and homeostasis that can be harnessed to eradicate infections, promote tissue resilience, and restore health after an infectious attack.

With a Ph.D. in artificial intelligence and computer vision and postgraduate training in biomedical imaging & computational neuroscience, Dr. Ehsan Adeli solves critical problems in healthcare and neuroscience.

Dr. Vanessa Barone studied molecular biology at Università delle Scienze di Torino, Italy and then pursued her PhD in the Carl-Philipp Heisenberg group at the Institute of Science and Technology Austria in Vienna, Austria. There she investigated how cell-cell contacts regulate cell differentiation of mesendodermal progenitors during zebrafish gastrulation, finding a positive feedback loop between cell-cell contacts and Nodal signalling that determines cell fate decisions.

Dr. Vayu Hill-Maini fell in love with cooking at a young age in his multicultural home in Stockholm, Sweden. He first moved to the U.S to work in restaurants, but the flavors, textures, and sensations of the kitchen eventually led him to scientific research. He received his B.A in Chemistry and Biology at Carleton College in 2015. He completed his PhD in Biochemistry from Harvard University in 2020, where he worked in the lab of Emily Balskus to characterize strains and enzymes from human gut microbiota responsible for the metabolism of drugs and dietary compounds.

Understanding mechanisms of metabolic regulation in physiology and disease forms the basis for developing therapies to treat diseases in which metabolism is perturbed. Dr. Haopeng Xiao devises novel mass spectrometry (MS)-based proteomics technologies, combined with data science, to systematically discover mechanisms of metabolic regulation over protein function. His strategies established the first tissue-specific landscape of protein cysteine redox regulation during aging, elucidating mechanisms of redox signaling in physiology that remained elusive for decades. Dr.

Dr. Guolan Lu's lab focuses on developing and integrating imaging, AI, and spatial omics technologies to uncover disease and therapeutic mechanisms. Their ultimate goal is to advance next-generation therapeutics to improve patient outcomes and cure diseases.

Dr. Ivana Maric is an Assistant Professor in the Pediatrics Department at the Stanford University School of Medicine. Her research focuses on applying machine learning to improving maternal and neonatal health. Her main focus has been on developing machine learning models for early prediction of adverse outcomes of pregnancy from omics and electronic health records data, that could guide development of low-cost, point of care diagnostic tools. Her main interest is in solutions that are applicable worldwide and especially in low-resource settings.

Dr. Jonathan Klein's research interests include preventive services, confidentiality, access to care, youth development, tobacco control, and the translation of research into clinical and public health practice and global child health policy. Current projects address engagement of clinical leaders in countries and communities in health care delivery improvement, accountability measurement, and advocacy for adolescent health, comprehensive sexuality education, and non-communicable disease prevention.